All-trans-retinoic acid and idole-3-acetic acid inhibit methionine adenosyltransferase activity in human tumor cells

Chinese Pharmaceutical Journal

Volumn 49, Issue 2, 1997, Pages 61-76

  Lai, Jem Min ^a   Wu, Li Tzu ^a   Chung, Jing Gung ^a   Huang, Li Jiau ^a   Liau, Ming Cheng ^a   Kuo, Sheng Chu ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

All trans retinoic acid (ATRA); Indole 3 acetic acid (IAA); Methionine; Methionine adenosyltransferase (MAT(LT); S adenosylmethionine

Indexed keywords

INDOLEACETIC ACID; METHIONINE ADENOSYLTRANSFERASE; RETINOIC ACID;

ARTICLE; BLADDER CARCINOMA; CELL LINE; CELL STRAIN HL 60; COLON ADENOCARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; TUMOR CELL;

EID: 2642672830     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Liau, M. C.; Lin, G. W.; Hurlbert, R. B. Partial Purification and Characterization of Tumor and Liver S-Adenosylmethionine Synthetases. Cancer Res. 1977, 37, 427-435.
2. Liau, M. C.; Chang, C. F.; Becker, F. F. Alternation of S-Adenosylmethionine Synthetases During Chemical Hepatocarcinogenesis and in Resulting Carcinomas. Cancer Res. 1979, 397, 2113-2119.
3. Liau, M. C.; Burzynski, S. R. Altered Methylation Complex Isozymes as Selective Targets for Cancer Chemotherapy. Drugs Exptl. Clin. Res. 1986, 12 (suppl 1), 77-86.
4. Kappler, F.; Hai, T. T.; Hampton, A. Isozyme Specific Enzyme Inhibitor, 10 Adenosine 5-Triphosphate Derivatives as Substrates or Inhibitors of Methionine Adenosyltransferase of Rat Normal and Hepatoma Tissues. J. Med. Chem. 1986, 29, 318-322.
5. Liau, M. C.; Lee, S. S.; Burzynski, S. R. Differentiation Inducing Components of Antineoplaston A5. Adv. Exptl. Clin. Chemother. 1988, 6, 9-25.
6. Liau, M. C.; Burzynski, S. R. Separation of Active Anticancer Components of Antineoplaston A2, A3 and A5. Internat. J. Tiss. React. 1990, 12 (suppl.), 1-18.
7. Burzynski, S. R. Antineoplastons: Biochemical Defense Against Cancer. Physiol. Chem. Phys. 1976, 8, 275-279.
8. Liau, M. C.; Burzynski, S. R. Hypomethylation of Nucleic Acids: A Key to the Induction of Terminal Differentiation. Internat. J. Exptl. Clin. Chemother. 1989, 2, 187-199.
9. Lee, S. S.; Burzynski, S. R. Induction of Differentiation of HL-60 Human Promyelocytic Leukemia Cells by Antineoplaston A5. Internat. J. Tiss. React. 1990, 12 (suppl.), 37-42.
10. Liau, M. C.; Liau, C. P.; Burzynski S. R. Potentiation of Induced Terminal Differentiation by Phenylacetic Acid and Related Chemicals. Internat. J. Exptl Clin. Chemother. 1992, 5, 9-17.
11. Tuncali, T. The Effect of Retinoids on the Growth and Differentiation of Colon Cancer Cells. Diss. Abstr Int. 1995, [B] 55 (10), 4235.
12. Chatterjee, R.; Bandyopadhyay, U.; Bhattacharyya, D.; Banerjee, R. K. Inhibition of Intestinal Peroxidase Activity by Nonsteroidal Antiinflammatory Drugs. Biochimica et Biophysica acta. 1993, 1161, 168-176.
13. Bartel, B.; Fink, G. R. ILR1, An Amidohydrolase that Release Active Indole-3-acetic Acid from Conjugates. Science 1995, 268, 1745-1748.
14. Azerszen, J. B.; Szcczyglowski, K.; Bandurski, R. S. Iaglu, a Gene from Zea mays Involved in Conjugation of Growth Hormone Indole-3-acetic Acid. Science 1994, 265, 1699-1701.
15. Candeias, L. P.; Folkes, L. K. Porssa, M.; Parrick, J.; Wardman, P. Enhancement of Lipid Peroxidation by Indole-3-acetic Acid and Derivatives: Substituent Effects. Free radical Research 1995, 23, 403-418.
16. Chau, I-Ju. Synthesis of Certain Indole-3-acetamides as Cell Differentiation Inducer. Master Thesis; China Medical College, Taichung, R.O.C., 1995.
17. Hamedani, M. P.; Vlara, K.; Qi, X.; Welham, K. J.; Gibbon, W. A. Two Dimensional High-performance Liquid Chromatographic Method for Assaying S-Adenosyl-L-methionine and its Related Metabolites in Tissues. J. Chromatogr. 1993, 619, 191-198.
18. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-dye Binding. Anal. Biochem. 1976, 7, 248-254.
19. Cleland, W. W. The Statistical Analysis of Enzyme Kinetics Data. Adv. Enzymol. 1967, 29, 1-32.
20. Hofmam, S. L. Southwestern Internal Medicine Conference: Retinoids "Differentiation Agents" for Cancer Treatment and Prevention. Am. J. Med. Sci. 1992, 304, 202-213.
21. Lapeyre, J. N.; Walker, M. S.; Becker, F. F. DNA Methylation and Methylase Levels in Normal and Malignant Mouse Hepatic Tissues. Carcinogenesis 1981, 2, 873-878.
22. Kantiainen, J.; Jones, P. A. DNA Methyltransferase Levels in Tumorigenic and Non Tumorigenic Cells in Culture. J. Biol. Chem. 1986, 261, 1584-1598.
23. Huang, M.-E.; Ye, Y.-C.; Chen, S.-R.; Chai, J.-R.; Lu, J.-X.; Zhoa, L.; Gu, L.-J.; Wang, Z.-Y. Use of All-trans-retinoic Acid in the Treatment of Acute Promyelocytic Leukemia. Blood. 1988, 72, 567-572.
24. Warrell, P. P. Jr.; Frankel, S. R.; Miller, W. H. Jr.; Scheinberg, D. A.; Itri, L. M.; Hittelman, W. N.; Vayas, R.; Andreeff, M.; Tafuri, A.; Jakubowski, A. Differentiation Therapy of Acute Promyelocytic Leukemia with Retinoin (all-trans-retinoic acid). New Eng. J. Med. 1991, 324, 1385-1393.
25. Tsai, S.; Collins, S. A. A Dominant Negative Retinoic Acid Receptor Blocks Neutrophil Differentiation at the Promyelocyte Stage. Proc. Nat. Acad. Sc. USA. 1993, 90, 7153-7157.
26. Degos, L.; Dombret, H.; Chomiene, C.; Daniel, M. T.; Miclea, J. M.; Chastang, C.; Castagne, S.; Fenaux, P. All-trans-retinoic Acid as a Differentiation Therapy for Acute Promyelocytic Leukemia. Blood 1996, 765, 1704-1709.
27. Borden, E. C.; Lotan, R.; Levens, D.; Young, C. W; Waxman, S. Differentiation Therapy of Cancer: Laboratory and Clinical Investigations. Cancer Res. 1993, 53, 4109-4115.
28. Smith, M. A.; Parkison, D. R.; Cheson, B. D.; Friedman, M. A. Retinoids in Cancer Therapy. J. Clin. Oncol. 1992, 10, 839-886.
29. Lippman, S. M.; Glissan, B. S.; Kavanagh, J. J.; Lotan, R.; Hong, W. K.; Paredes-Espinoza, M.; Hittelman, W. N.; Holdener, E. E.; and Krakoff, I. H. Retinoic Acid and Interferon Combination Studies in Human Cancer. Eur. J. Cancer 1993, 29A (suppl.5) S9-13.
30. Moore, D. M.; Kalvakolanu, D. V.; Lippman, S. M.; Kavanagh, J. J.; Hong, W. K.; Borden, E. C.; Paredes-Espinoza, M.; Krakoff, I. H. Retinoic Acid and Interferon in Human Cancer: Mechanistic and Clinical Studies. Seminar in Hematology 1994, 31 (suppl. 5), 31-37.
31. Adamson, P. C. Clinical and Pharmacokinetic Studies of All-trans-retinoic Acid in Pediatric Patients with Cancer. Leukemia 1994, 8 (suppl. 3), S22-25.
32. Love, J. M.; Gudas L. J. Vitamin A, Differentiation and Cancer. Current Opinion in Cell Biology 1994, 6, 825-831.
33. Schaefer, H.; Reichert, U. Retinoids and Their Perspective in Dermatology. Nouvelles Dermatogiques 1920, 9, 3-6.
34. Lotan, R. Suppression of Squamous Cell Carcinoma Growth and Differentiation by Retinoids. Cancer Res. 1994, 54, 1987-1990.
35. Tallman, M. S.; Weirnik, P. H. Retinoids in Cancer Treatment. J. Clin. Pharmacol. 1992, 32, 868-888.
36. Bollag, W.; Holdener, E. E. Retinoids in Cancer Prevention and Therapy. Ann. Oncol. 1992, 3, 513-526.
37. Chen, L. C.; Sly, L.; De Luca, L. M. High Dietary Retinoic Acid Prevents Malignant Conversion of Skin Papillomas Induced by a Two-stage Carcinogenesis Protocol in Female SENCAR Mice. Carcinogenesis 1994, 15, 2283-2386.
38. Ross, S. A.; Ahrens, R. A.; De Luca, L. M. Retinoic Acid Enhances Adhesiveness, Laminin and Integrin Beta 1 Synthesis and Retinoic Acid Receptor Expression in F9 Teratocarcinoma Cells. J. Cell Physiol. 1994, 159, 263-273.
39. Beere, H. M.; Hickman, J. A. Differentiation: A Suitable Strategy for Cancer Chemotherapy. Anti-cancer Drug Design 1993, 8, 299-322.